Drug
Laroprovstat clinical trials
Also written AZD0780.
- studies test it
- 17
- open now
- 1
- in phase 3
- 4
- first study started
- 2022
Keep track of what changes. Save the laroprovstat studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
- AZD0780
- 17
Studies by the year they started
17 studies that test it; most in 2024 (7)
| Year | Studies |
|---|---|
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 7 |
| 2025 | 5 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 10
- Phase 2
- 4
- Phase 3
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 17 · Other 0
Often tested with
Tested in the same studies.
Rosuvastatin (3) · AZD4954 (1) · Metformin (1) · Bempedoic acid (1) · Itraconazole (1) · Carbamazepine (1) · Midazolam (1) · Ethinyl estradiol, levonorgestrel drug combination (1)
Studies
Open first, then newest update. How each study uses laroprovstat is read from its arms, and is right about nine times in ten.
Testing it · 17
- A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First EventRecruitingPhase 3AstraZenecaNCT07000357Written as AZD0780
- A Study to Investigate the Effect of AZD0780 Tablets in Combination With Rosuvastatin Tablets on Low Density Lipoprotein Cholesterol Levels (LDL-C) in Adult Participants With DyslipidaemiaCompletedPhase 2AstraZenecaNCT07218900Written as AZD0780
- A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD0780 in Healthy SubjectsCompletedPhase 1AstraZenecaNCT05384262Written as AZD0780
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With DyslipidaemiaActive, not recruitingPhase 2/3AstraZenecaNCT06834932Written as AZD0780
- A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD EventActive, not recruitingPhase 3AstraZenecaNCT07000123Written as AZD0780
- A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of AZD4954 and Vice Versa in Healthy AdultsCompletedPhase 1AstraZenecaNCT07513571Written as Laroprovstat
- A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFHActive, not recruitingPhase 3AstraZenecaNCT07000136Written as AZD0780
- A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics With AZD0780 Following Repeated Dose Administration in Healthy Adults With Elevated LDL-C LevelsCompletedPhase 1AstraZenecaNCT07423598Written as AZD0780
- A Study to Assess the Effect of AZD0780 on Ambulatory Blood PressureCompletedPhase 2AstraZenecaNCT06692764Written as AZD0780
- A Study to Investigate the Effect of AZD0780 on Metformin Pharmacokinetics in Healthy Adult Volunteers Aged 18 to 55 YearsCompletedPhase 1AstraZenecaNCT07216131Written as AZD0780
- A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With DyslipidemiaCompletedPhase 2AstraZenecaNCT06173570Written as AZD0780
- A Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Combinations in Healthy Adults With Elevated LDL-C.CompletedPhase 1AstraZenecaNCT06742853Written as AZD0780
- An ADME Study of [14C]AZD0780 in Healthy Male SubjectsCompletedPhase 1AstraZenecaNCT05817461Written as AZD0780 tablet
- A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of Rosuvastatin.CompletedPhase 1AstraZenecaNCT05787002Written as AZD0780
- An Open-label Study in Healthy Participants to Evaluate AZD0780 as an Object or Precipitant of CYP3A4-mediated Drug-drug InteractionsCompletedPhase 1AstraZenecaNCT06671405Written as AZD0780
- A Phase I Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD0780CompletedPhase 1AstraZenecaNCT06592482Written as AZD0780
- Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD0780CompletedPhase 1AstraZenecaNCT06576765Written as AZD0780
As the comparator · 1 — what is tested is compared with laroprovstat
Codes
What other systems call laroprovstat · ClinicalTrials.gg INT015852
- UNII (FDA) 9EEL3YMY29LAROPROVSTATOne source FDA
- NCI Thesaurus C211749LaroprovstatOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 9EEL3YMY29 | LAROPROVSTAT | One source FDA |
| NCI Thesaurus | C211749 | Laroprovstat | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.